Approximately one in eight Americans has taken a GLP-1 or glucagon-like peptide-1 receptor agonist. These medications were originally developed to help manage type 2 diabetes, but they also support ...

If you've been denied access to a GLP-1 medication for weight loss, you are not alone. However, there are new science-backed options you should know about that don't require a prescription. Health ...

Popular drugs credited with shrinking waistlines and controlling blood sugar may also take the edge off alcohol’s buzz, according to a new study. Researchers at Virginia Tech's Fralin Biomedical ...

After hitting a record high, the U.S. rate of obesity is falling, as the number of people taking GLP-1 medications rises stockvisual/Getty The rate of obese Americans has declined three years after ...

Please provide your email address to receive an email when new articles are posted on . There are limited numbers of FDA-approved medications to treat alcohol and substance use disorders. Preclinical ...

The obesity rate in the U.S. has seen a marked decline over the last three years, as the share of Americans who report using GLP-1 agonists for weight loss skyrockets, according to data from Gallup.

Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded studies raise questions. The reviews were commissioned by the World Health ...

Dothée is a writer in Los Angeles. On Oct. 16, President Trump promised to slash the price of brand-name GLP-1 drugs like Ozempic and Wegovy to $150 a month. Even after a top health official suggested ...

For most of my adult life, I’ve felt helpless about being overweight. When I met with a doctor a few years ago to discuss my high cholesterol, he held up a hunk of faux flesh meant to model a pound of ...

Unregulated compounding pharmacies are selling unapproved, knockoff versions of GLP-1 weight-loss drugs. The FDA has issued warnings about contamination and incorrect dosages in these copycat ...

GLP-1 drugs were initially developed for type 2 diabetes but are now widely used to treat obesity. Novo Nordisk and Eli Lilly lead in GLP-1 drug production, with others like Viking Therapeutics ...

While many patients experience common side effects from GLP-1 medications — such as nausea and bloating, new research has revealed an unexpected positive effect beyond weight loss. A major study ...